Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

u-blox AG: u-blox’s cloud-based positioning solution receives the 2022 IoT Evolution Asset Tracking Award
u-blox AG: u-blox’s cloud-based positioning solution receives the 2022 IoT Evolution Asset Tracking Award
u-blox AG: u-blox’s cloud-based positioning solution receives the 2022 IoT Evolution Asset Tracking Award
Schaffner Capital Markets Day: Well positioned and focused on strategic growth targets
Schaffner Capital Markets Day: Well positioned and focused on strategic growth targets
Schaffner Capital Markets Day: Well positioned and focused on strategic growth targets
Annual General Meeting of Kuros Biosciences approves all resolutions
Annual General Meeting of Kuros Biosciences approves all resolutions
Annual General Meeting of Kuros Biosciences approves all resolutions
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash
Press release: Leonteq expects record profits for the first half of 2022
Press release: Leonteq expects record profits for the first half of 2022
Press release: Leonteq expects record profits for the first half of 2022
Private Equity Holding AG: Shareholders of Private Equity Holding AG approve all proposals by the Board of Directors
Private Equity Holding AG: Shareholders of Private Equity Holding AG approve all proposals by the Board of Directors
Private Equity Holding AG: Shareholders of Private Equity Holding AG approve all proposals by the Board of Directors
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Key Figures

31.05.2022
Key Figures 31.05.2022
Key Figures 31.05.2022
Innovative and sustainable – Implenia among the top three finalists at the German Construction Award 2022
Innovative and sustainable – Implenia among the top three finalists at the German Construction Award 2022
Innovative and sustainable – Implenia among the top three finalists at the German Construction Award 2022
Mobimo Holding AG: Mobimo’s current ESG reporting
Mobimo Holding AG: Mobimo’s current ESG reporting
Mobimo Holding AG: Mobimo’s current ESG reporting
DGAP-News: Highlight Communications AG: Highlight Group publishes results for the first quarter of 2022
DGAP-News: Highlight Communications AG: Highlight Group publishes results for the first quarter of 2022
DGAP-News: Highlight Communications AG: Highlight Group publishes results for the first quarter of 2022
Burkhalter Shareholders’ Meeting approves merger with Poenina
Burkhalter Shareholders’ Meeting approves merger with Poenina
Burkhalter Shareholders’ Meeting approves merger with Poenina
Perfect solution for MSPs: Sophos’ Cybersecurity System is now available via the ALSO Cloud Marketplace
Perfect solution for MSPs: Sophos’ Cybersecurity System is now available via the ALSO Cloud Marketplace
Perfect solution for MSPs: Sophos’ Cybersecurity System is now available via the ALSO Cloud Marketplace
u-blox AG: u-blox increases revenue and EBITDA guidance for FY 2022
u-blox AG: u-blox increases revenue and EBITDA guidance for FY 2022
u-blox AG: u-blox increases revenue and EBITDA guidance for FY 2022
Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial
Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial
Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial
Rieter: Challenging First Half of 2022 Despite Exceptionally High Order Backlog

Ad hoc announcement pursuant to Art. 53 LR
Rieter: Challenging First Half of 2022 Despite Exceptionally High Order Backlog Ad hoc announcement pursuant to Art. 53 LR
Rieter: Challenging First Half of 2022 Despite Exceptionally High Order Backlog Ad hoc announcement pursuant to Art. 53 LR
DGAP-News: Supplement to the press release from 02.05.2022 - Highlight Group with positive sales and earnings growth in fiscal year 2021
DGAP-News: Supplement to the press release from 02.05.2022 - Highlight Group with positive sales and earnings growth in fiscal year 2021
DGAP-News: Supplement to the press release from 02.05.2022 - Highlight Group with positive sales and earnings growth in fiscal year 2021
ALSO strengthens Investor Relations
ALSO strengthens Investor Relations
ALSO strengthens Investor Relations
Annual General Meeting reverts to standard format and passes the recommendations proposed by the Board of Directors
Annual General Meeting reverts to standard format and passes the recommendations proposed by the Board of Directors
Annual General Meeting reverts to standard format and passes the recommendations proposed by the Board of Directors
u-blox AG: u-blox launches world’s smallest LTE Cat 4 module with global coverage and 2G/3G fallback
u-blox AG: u-blox launches world’s smallest LTE Cat 4 module with global coverage and 2G/3G fallback
u-blox AG: u-blox launches world’s smallest LTE Cat 4 module with global coverage and 2G/3G fallback
LEM announces record financial results for full year 2021/22
LEM announces record financial results for full year 2021/22
LEM announces record financial results for full year 2021/22
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
CALIDA Holding AG: CALIDA GROUP successfully completes acquisition of premium lingerie brand Cosabella
CALIDA Holding AG: CALIDA GROUP successfully completes acquisition of premium lingerie brand Cosabella
CALIDA Holding AG: CALIDA GROUP successfully completes acquisition of premium lingerie brand Cosabella
u-blox AG: u-blox announces CEO transition effective 1 January 2023
u-blox AG: u-blox announces CEO transition effective 1 January 2023
u-blox AG: u-blox announces CEO transition effective 1 January 2023
Changes to the Executive Committee of Comet Group
Changes to the Executive Committee of Comet Group
Changes to the Executive Committee of Comet Group